EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 20 July 2023

Rethinking the EU general pharmaceutical legislation for a competitive, more resilient and healthier Europe

How can the Pharma Legislation help close the gap with other regions?

As discussions surrounding the revision of the EU pharmaceutical legislation take place, EFPIA Director General Nathalie Moll addresses how to ensure equitable access to medicines for all Europeans and how to foster a highly competitive and innovative pharmaceutical industry.

Are European policy makers losing interest in health?
14 July 2023 - Thomas Allvin

What the European Semester 2023 tells us of the future of European health policy Read more

Events

Unlocking the potential of new oncology treatments
12 September 2023 (Virtual event)

A cross-stakeholder discussion on improving the understanding, acceptance and use of oncology-relevant endpoints in... Read more

Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis...
26 September 2023 (Online)

Moving towards a new Alzheimer’s disease detection and diagnosis pathway Read more

DIA Medical Information and Communications Conference
27 September 2023 (Brussels)

Engage and exchange with the biggest medical information community in Europe Read more

33rd Alzheimer Europe Conference
16 October 2023 (Helsinki, Finland, & virtual)

New opportunities in dementia care, policy and research Read more

What we are reading

NIRO - Navigating Innovation & Research Opportunities
On 18 July 2023 (niroglobal)

Discover this new tool to look for research & innovation fundings.

Clinical trials research needs recommendations
On 11 July 2023 (RareDiseaseMoonshot)

The Clinical Trials Research Needs Recommendations aim to inform funders of research programmes who plan projects... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu